Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Medpace Holdings NASDAQ MEDP
$389.77 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Life Sciences Tools & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 40 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

12.47B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
12.52B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.30
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
32.00M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
27.16 %
Upcoming events Medpace Holdings All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Medpace Holdings

Stock analysis Medpace Holdings

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
39.91 27.54
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
22.32 5.10
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
32.77 22.63
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.12 0.47
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
46.54 13.20

Price change Medpace Holdings per year

105.48$ 199.04$
Min Max

Summary analysis Medpace Holdings

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Medpace Holdings

Revenue and net income Medpace Holdings

All parameters
Stock news Medpace Holdings All news
25 April 2023 в 14:37

S&P 500 Futures Drop in Premarket Trading; Medpace Holdings, Ionis Pharmaceuticals Lead

11 June 2022 в 00:20

MedPace Holdings Increases Stock Repurchase Plan by $50M

11 June 2022 в 00:15

MedPace Holdings Increases Stock Repurchase Plan by $50M

26 October 2021 в 14:35

Premarket Movers: Medpace Holdings, Logitech International, Polaris

About company Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Address:
5375 Medpace Way, Cincinnati, OH, United States, 45227
Company name: Medpace Holdings
Issuer ticker: MEDP
ISIN: US58506Q1094
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2016-08-11
Sector: Healthcare
Industry: Life Sciences Tools & Services
Site: https://www.medpace.com

On which stock exchange are Medpace Holdings (MEDP) stocks traded?

Medpace Holdings (MEDP) stocks are traded on NASDAQ.

What is the ticker of Medpace Holdings stocks (MEDP)?

The stock ticker of Medpace Holdings’s stocks or in other words, the code is MEDP. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Medpace Holdings (MEDP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Medpace Holdings (MEDP) belongs to the «Healthcare» sector and the «Life Sciences Tools & Services» industry.

In what currency are Medpace Holdings (MEDP) stocks traded?

Medpace Holdings (MEDP) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Medpace Holdings (MEDP) stocks today?

The current price of Medpace Holdings stocks on 26.04.2024 is 389.77 dollars. per share.

What is the dynamics of Medpace Holdings (MEDP) stocks from the beginning of the year?

Medpace Holdings (MEDP) quotes have increased by 27.55% from the beginning of the year up to 389.77 dollars. per 1 stocks.

How much did Medpace Holdings (MEDP) stocks increase in апреле 2024?

This month Medpace Holdings (MEDP) quotes have increased by -2.07% to 389.77 dollars. per share.

How much are Medpace Holdings (MEDP) stocks worth?

Today, on October, 26.04.2024 Medpace Holdings’s (MEDP) stocks cost 389.77 dollars..

What is the market capitalization of Medpace Holdings (MEDP)?

Capitalization is the market value of Medpace Holdings (MEDP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 26.04.2024, the market capitalization of Medpace Holdings (MEDP) is estimated at about 12473029770 dollars.